Todd M. Gleason

Mr. Gleason’s representative experience includes advising:

Manufacturing

• Bridgeport Fittings, a leading manufacturer in high-performing electrical fittings in its acquisition by NSI Industries, a leading provider of electrical products*
• The first offshore wind farm company in the United States in connection with the project financing for its 5-turbine test project off of the coast of Rhode Island*
• Sellers of a national electrical parts distribution company to a US subsidiary of a French publicly held corporation*
• Supply Chain, Procurement, and Distribution
• Board counsel to a supply chain company providing exclusive procurement and distribution services to a national quick service restaurant brand and its franchisees*

Retail/Entertainment

• Marcolin Group, in the perpetual license agreement transaction with Estee Lauder Companies Inc. and Tom Ford brand
• Sale of Luxury Brand Holdings, parent company of Ross-Simons, to Nonantum Capital Partners*

Consulting and Professional Services

• An industry-leading consulting firm engaged in telecommunications, data services, and media transaction consulting projects for private equity and investment firms in the sale to a global consulting firm*

Technology

• Members of a predictive analytics software company in an equity sale to an Irish public company*
• Intentsify, a software company providing intent data services in the investment from BV Investment Partners (BV), a middle-market private equity firm
• A mariculture research and processing technology company, utilizing loop cord media and mussel technology for wastewater treatment applications in a buyout transaction with former shareholders*

Debt and Equity Financing

• A mezzanine credit and private equity investment firm concentrated in emerging growth companies in negotiating debt and equity financing documents in a number of industries, including technology, data center, medical transportation, software services, and solar energy projects*

Financial Services

• Shareholders of a national foreign exchange services company in its sale to a private-equity owned strategic acquirer in the United Kingdom*

Healthcare and Bioscience

• A publicly traded drug development and discovery company in the sale of a manufacturing sub-division to a strategic acquirer*
• Shareholders of a national medical laboratory providing drug monitoring services in a sale to a private equity firm focused on health care transactions*
• Shareholders of a national network of opioid treatment centers in an equity sale to a US public healthcare company*
• Shareholders of a leading genetic testing development company in an equity sale to a US public company*
• The first for profit subsidiary of a major regional pediatric hospital, engaged in pediatric genomic medicine and genetic testing; acted as outside counsel*

*Matter handled prior to joining Latham